February 21, 2025
AI for human health
Dear reader
After a brief period in the spotlight during the pandemic, the use of digital tools in healthcare once again fell out of focus. However, AI is now providing renewed momentum for start-ups that position themselves at the interface of life sciences and IT. For example, InVirtuoLabs has raised EUR 2.85 million in its first funding round. The Ticino-based start-up aims to halve the development time and costs in pharmaceutical research using AI and advanced molecular simulations.
Virtuosis offers an integrated AI solution that analyses vocal biomarkers – such as tone, timbre and rhythm – to assess mental, cognitive, respiratory, metabolic and cardiovascular health. The EPFL spin-off is expanding rapidly and has now opened a branch in France.
Digital health start-ups Arbrea Labs and machineMD are among four companies in the life sciences sector that are new holders of the Innosuisse certificate. Several start-ups that focus on human health have been accepted into Microsoft’s AI Tech Accelerator Community together with more than 20 other companies. These include Navis Bio, which supports drug development with data-driven insights for target assessment and trial design, and Novigenix, which uses AI and RNA sequencing to advance drug discovery and cancer diagnostics.
OptimalPSI focuses on development of a patient-specific spinal fusion implant using advanced computational strategies: the ETH Zurich spin-off has now secured CHF 150,000 from Venture Kick. The second Venture Kick winner this week was Mimic Robotics, which develops collaborative robots with humanoid hands powered by generative AI.
In terms of transactions, it was noticeable this week that although exits remain in short supply, private equity investments and secondary sales are on the rise. For example, Five Elms Capital has invested USD 75 million of growth capital in RoomPriceGenie. The founders are still invested and active in the company, but some existing investors were bought out, adding a secondary component to the transaction.
German tech investor Maguar Capital, which specialises in B2B software investment in the DACH region, has taken over Swiss digital signage pioneer Navori Labs. And private equity firm Astorg has acquired a majority stake in data management services company Redslim.
I would like to remind you once again of the impending deadlines for >>venture>> and the Swiss Fintech Awards. And the application deadline for the ESA BIC Accelerator is also fast approaching.
The WA de Vigier Awards’ Selection Day will take place next Tuesday, with the pitches streamed live on the foundation’s website. Last but not least, a note about Swiss Nordic Bio 2025: the high-level partnering and investor conference, which aims to connect healthcare innovations, investors and industry, will take place in Zurich in March.
Have a good weekend.
Stefan Kyora
Editor in Chief, Startupticker.ch